These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38477411)

  • 21. Enzyme Core Spherical Nucleic Acid That Enables Enhanced Cuproptosis and Antitumor Immune Response through Alleviating Tumor Hypoxia.
    Huang Y; Liu X; Zhu J; Chen Z; Yu L; Huang X; Dong C; Li J; Zhou H; Yang Y; Tan W
    J Am Chem Soc; 2024 May; 146(20):13805-13816. PubMed ID: 38552185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copper(II)-Based Nano-Regulator Correlates Cuproptosis Burst and Sequential Immunogenic Cell Death for Synergistic Cancer Immunotherapy.
    Luo Y; Luo X; Ru Y; Zhou X; Liu D; Huang Q; Linghu M; Wu Y; Lv Z; Chen M; Ma Y; Huang Y; Wang J
    Biomater Res; 2024; 28():0039. PubMed ID: 38938647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy.
    Xu Y; Liu SY; Zeng L; Ma H; Zhang Y; Yang H; Liu Y; Fang S; Zhao J; Xu Y; Ashby CR; He Y; Dai Z; Pan Y
    Adv Mater; 2022 Oct; 34(43):e2204733. PubMed ID: 36054475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhalable metal-organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy.
    Yan C; Liu Y; Zhao G; Yang H; Lv H; Li G; Li Y; Fu Y; Sun F; Feng Y; Li Y; Zhao Z
    Acta Pharm Sin B; 2024 May; 14(5):2281-2297. PubMed ID: 38799628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal Clearable Ultrasmall Single-Crystal Fe Nanoparticles for Highly Selective and Effective Ferroptosis Therapy and Immunotherapy.
    Liang H; Wu X; Zhao G; Feng K; Ni K; Sun X
    J Am Chem Soc; 2021 Sep; 143(38):15812-15823. PubMed ID: 34473493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondria-Targeted Multifunctional Nanoparticles Combine Cuproptosis and Programmed Cell Death-1 Downregulation for Cancer Immunotherapy.
    Li Y; Liu J; Weichselbaum RR; Lin W
    Adv Sci (Weinh); 2024 Sep; 11(35):e2403520. PubMed ID: 39013093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Self-Amplifying ROS-Responsive Nanoplatform for Simultaneous Cuproptosis and Cancer Immunotherapy.
    Wu H; Zhang Z; Cao Y; Hu Y; Li Y; Zhang L; Cao X; Wen H; Zhang Y; Lv H; Jin X
    Adv Sci (Weinh); 2024 Jun; 11(23):e2401047. PubMed ID: 38569217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Copper homeostasis and cuproptosis in mitochondria.
    Tian Z; Jiang S; Zhou J; Zhang W
    Life Sci; 2023 Dec; 334():122223. PubMed ID: 38084674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-Site Nanozymes with a Highly Conjugated Coordination Structure for Antitumor Immunotherapy via Cuproptosis and Cascade-Enhanced T Lymphocyte Activity.
    Liu Y; Niu R; Zhao H; Wang Y; Song S; Zhang H; Zhao Y
    J Am Chem Soc; 2024 Feb; 146(6):3675-3688. PubMed ID: 38305736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer.
    Song R; Li T; Ye J; Sun F; Hou B; Saeed M; Gao J; Wang Y; Zhu Q; Xu Z; Yu H
    Adv Mater; 2021 Aug; 33(31):e2101155. PubMed ID: 34170581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.
    Gray MJ; Gong J; Hatch MM; Nguyen V; Hughes CC; Hutchins JT; Freimark BD
    Breast Cancer Res; 2016 May; 18(1):50. PubMed ID: 27169467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photothermal Ferrotherapy - Induced Immunogenic Cell Death via Iron-Based Ternary Chalcogenide Nanoparticles Against Triple-Negative Breast Cancer.
    Wu Q; Li Z; Zhou X; Wei Z; Ramadan S; Xu Y; Xu L; Li D
    Small; 2024 May; 20(20):e2306766. PubMed ID: 38095479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mild-Photothermal Effect Induced High Efficiency Ferroptosis-Boosted-Cuproptosis Based on Cu
    Chen W; Xie W; Gao Z; Lin C; Tan M; Zhang Y; Hou Z
    Adv Sci (Weinh); 2023 Nov; 10(33):e2303694. PubMed ID: 37822154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma.
    Shen Y; Li D; Liang Q; Yang M; Pan Y; Li H
    Front Immunol; 2022; 13():1029092. PubMed ID: 36733399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade.
    Qin Y; Vasilatos SN; Chen L; Wu H; Cao Z; Fu Y; Huang M; Vlad AM; Lu B; Oesterreich S; Davidson NE; Huang Y
    Oncogene; 2019 Jan; 38(3):390-405. PubMed ID: 30111819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
    Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
    Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifaceted Carbonized Metal-Organic Frameworks Synergize with Immune Checkpoint Inhibitors for Precision and Augmented Cuproptosis Cancer Therapy.
    Zhao C; Tang X; Chen X; Jiang Z
    ACS Nano; 2024 Jul; 18(27):17852-17868. PubMed ID: 38939981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNAzyme-Mediated Cascade Nanoreactor for Cuproptosis-Promoted Pancreatic Cancer Synergistic Therapy.
    Yu Q; Zhou J; Liu Y; Li XQ; Li S; Zhou H; Kang B; Chen HY; Xu JJ
    Adv Healthc Mater; 2023 Nov; 12(28):e2301429. PubMed ID: 37548109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
    Song S; Zhang M; Xie P; Wang S; Wang Y
    Front Immunol; 2022; 13():978909. PubMed ID: 36341328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor Microenvironment Responsive Hollow Nanoplatform for Triple Amplification of Oxidative Stress to Enhance Cuproptosis-Based Synergistic Cancer Therapy.
    Xu W; Wang Y; Hou G; Wang J; Wang T; Qian J; Suo A
    Adv Healthc Mater; 2023 May; 12(13):e2202949. PubMed ID: 36716523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.